Physical Function Impairment of Older, HIV-Infected Adults is Associated with Cytomegalovirus Immunoglobulin Response

AIDS Research and Human Retroviruses

Volumn 31, Issue 9, 2015, Pages 905-912

  Erlandson, Kristine M ^a   Allshouse, Amanda A ^b   Rapaport, Eric ^a   Palmer, Brent E ^a   Wilson, Cara C ^a   Weinberg, Adriana ^a,c   Mawhinney, Samantha ^b   Campbell, Thomas B ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b Food Science and Human Nutrition   (United States)

^c University of Colorado Denver and Children s Hospital Colorado   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOMEGALOVIRUS ANTIBODY; GAMMA INTERFERON; IMMUNOGLOBULIN G; INTERLEUKIN 6; VIRUS ANTIBODY;

ADULT; AGE; AGED; ANTIBODY RESPONSE; ARTICLE; CASE CONTROL STUDY; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FUNCTIONAL DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; IMMUNOGLOBULIN BLOOD LEVEL; MALE; PRIORITY JOURNAL; TOBACCO USE; VIRUS IMMUNITY; COMPLICATION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; FITNESS; IMMUNOLOGY; MIDDLE AGED; MOTOR ACTIVITY; PATHOPHYSIOLOGY;

ANTIBODIES, VIRAL; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HIV INFECTIONS; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; MOTOR ACTIVITY; PHYSICAL FITNESS;

EID: 84940023216     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2015.0085     Document Type: Article

References (44)

1. Aiello AE, Haan MN, Pierce CM, et al.: Persistent infection, inflammation, and functional impairment in older Latinos. J Gerontol A Biol Sci Med Sci 2008;63:610-618.
2. Schmaltz HN, Fried LP, Xue QL, et al.: Chronic cytomegalovirus infection and inflammation are associated with prevalent frailty in community-dwelling older women. J Am Geriatr Soc 2005;53:747-754.
3. Naeger DM, Martin JN, Sinclair E, et al.: Cytomegalovirus-specific T cells persist at very high levels during longterm antiretroviral treatment of HIV disease. PLoS One 2010;5:e8886.
4. Sylwester AW, Mitchell BL, Edgar JB, et al.: Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects. J Exp Med 2005;202:673-685.
5. Almanzar G, Schwaiger S, Jenewein B, et al.: Long-term cytomegalovirus infection leads to significant changes in the composition of the CD8+ T-cell repertoire, which may be the basis for an imbalance in the cytokine production profile in elderly persons. J Virol 2005;79:3675-3683.
6. Khan N, Hislop A, Gudgeon N, et al.: Herpesvirus-specific CD8 T cell immunity in old age: Cytomegalovirus impairs the response to a coresident EBV infection. J Immunol 2004;173:7481-7489.
7. Vescovini R, Biasini C, Telera AR, et al.: Intense antiextracellular adaptive immune response to human cytomegalovirus in very old subjects with impaired health and cognitive and functional status. J Immunol 2010;184:3242-3249.
8. Hadrup SR, Strindhall J, Kollgaard T, et al.: Longitudinal studies of clonally expanded CD8 T cells reveal a repertoire shrinkage predicting mortality and an increased number of dysfunctional cytomegalovirus-specific T cells in the very elderly. J Immunol 2006;176:2645-2653.
9. Lurain NS, Hanson BA, Martinson J, et al.: Virological and immunological characteristics of human cytomegalovirus infection associated with Alzheimer disease. J Infect Dis 2013;208:564-572.
10. Moro-Garcia MA, Alonso-Arias R, Lopez-Vazquez A, et al.: Relationship between functional ability in older people, immune system status, and intensity of response to CMV. Age 2012;34:479-495.
11. Haeseker MB, Pijpers E, Dukers-Muijrers NH, et al.: Association of cytomegalovirus and other pathogens with frailty and diabetes mellitus, but not with cardiovascular disease and mortality in psycho-geriatric patients; a prospective cohort study. Immun Ageing 2013;10:30.
12. Wang GC, Kao WH, Murakami P, et al.: Cytomegalovirus infection and the risk of mortality and frailty in older women: A prospective observational cohort study. Am J Epidemiol 2010;171:1144-1152.
13. Savva GM, Pachnio A, Kaul B, et al.: Cytomegalovirus infection is associated with increased mortality in the older population. Aging cell 2013;12:381-387.
14. Roberts ET, Haan MN, Dowd JB, et al.: Cytomegalovirus antibody levels, inflammation, and mortality among elderly Latinos over 9 years of follow-up. Am J Epidemiol 2010;172:363-371.
15. Gkrania-Klotsas E, Langenberg C, Sharp SJ, et al.: Seropositivity and higher immunoglobulin G antibody levels against cytomegalovirus are associated with mortality in the population-based European prospective investigation of Cancer-Norfolk cohort. Clin Infect Dis 2013;56:1421-1427.
16. Burbelo PD, Ching KH, Morse CG, et al.: Altered antibody profiles against common infectious agents in chronic disease. PLoS One 2013;8:e81635.
17. Gianella S, Morris SR, Tatro E, et al.: Virologic correlates of anti-CMV IgG levels in HIV-1-infected men. J Infect Dis 2014;209:452-456.
18. Appay V, Fastenackels S, Katlama C, et al.: Old age and anti-cytomegalovirus immunity are associated with altered T-cell reconstitution in HIV-1-infected patients. AIDS 2011;25:1813-1822.
19. Hsue PY, Hunt PW, Sinclair E, et al.: Increased carotid intima-media thickness in HIV patients is associated with increased cytomegalovirus-specific T-cell responses. AIDS 2006;20:2275-2283.
20. Masia M, Robledano C, Ortiz de la Tabla V, et al.: Increased carotid intima-media thickness associated with antibody responses to varicella-zoster virus and cytomegalovirus in HIV-infected patients. PLoS One 2013;8: e64327.
21. Parrinello CM, Sinclair E, Landay AL, et al.: Cytomegalovirus immunoglobulin G antibody is associated with subclinical carotid artery disease among HIV-infected women. J Infect Dis 2012;205:1788-1796.
22. Hunt PW, Martin JN, Sinclair E, et al.: Valganciclovir reduces T cell activation in HIV-infected individuals with incomplete CD4+ T cell recovery on antiretroviral therapy. J Infect Dis 2011;203:1474-1483.
23. Erlandson KM, Allshouse AA, Jankowski CM, et al.: Association of functional impairment with inflammation and immune activation in HIV type 1-infected adults receiving effective antiretroviral therapy. J Infect Dis 2013;208:249-259.
24. Erlandson KM, Allshouse AA, Jankowski CM, et al.: Comparison of functional status instruments in HIVinfected adults on effective antiretroviral therapy. HIV Clin Trials 2012;13:324-334.
25. Erlandson KM, Allshouse AA, Jankowski CM, et al.: Functional impairment is associated with low bone and muscle mass among persons aging with HIV infection. J Acquir Immune Defic Syndr 2013;63:209-215.
26. Justice AC, Modur SP, Tate JP, et al.: Predictive accuracy of the Veterans Aging Cohort Study index for mortality with HIV infection: A North American cross cohort analysis. J Acquir Immune Defic Syndr 2013;62:149-163.
27. Harris PA, Taylor R, Thielke R, et al.: Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009;42:377-381.
28. Geist LJ and Dai LY: Cytomegalovirus modulates interleukin-6 gene expression. Transplantation 1996;62:653-658.
29. Mathei C, Vaes B, Wallemacq P, et al.: Associations between cytomegalovirus infection and functional impairment and frailty in the BELFRAIL Cohort. J Am Geriatr Soc 2011;59:2201-2208.
30. Marttila S, Jylhava J, Kananen L, et al.: Molecular mechanisms associated with the strength of the anti-CMV response in nonagenarians. Immun Ageing 2014;11:2.
31. Rothman KJ and Greenland S: Modern Epidemiology (2nd ed.). Lippincott Williams & Wilkins, Philadelphia, 1998.
32. Zhu J, Shearer GM, Marincola FM, et al.: Discordant cellular and humoral immune responses to cytomegalovirus infection in healthy blood donors: Existence of a Th1-type dominant response. Int Immunol 2001;13:785-790.
33. McVoy MA and Adler SP: Immunologic evidence for frequent age-related cytomegalovirus reactivation in seropositive immunocompetent individuals. J Infect Dis 1989;160:1-10.
34. Sinclair E, Tan QX, Sharp M, et al.: Protective immunity to cytomegalovirus (CMV) retinitis in AIDS is associated with CMV-specific T cells that express interferon-gamma and interleukin-2 and have a CD8+ cell early maturational phenotype. J Infect Dis 2006;194:1537-1546.
35. Weinberg A, Tierney C, Kendall MA, et al.: Cytomegalovirus-specific immunity and protection against viremia and disease in HIV-infected patients in the era of highly active antiretroviral therapy. J Infect Dis 2006;193:488-493.
36. Li H, Weng P, Najarro K, et al.: Chronic CMV infection in older women: Longitudinal comparisons of CMV DNA in peripheral monocytes, anti-CMV IgG titers, serum IL-6 levels, and CMV pp65 (NLV)-specific CD8 T-cell frequencies with twelve year follow-up. Exp Gerontol 2014; 54:84-89.
37. Li H, Margolick JB, Bream JH, et al.: Heterogeneity of CD4+ and CD8+ T-cell responses to cytomegalovirus in HIV-infected and HIV-uninfected men who have sex with men. J Infect Dis 2014;210:400-404.
38. Kern F, Bunde T, Faulhaber N, et al.: Cytomegalovirus (CMV) phosphoprotein 65 makes a large contribution to shaping the T cell repertoire in CMV-exposed individuals. J Infect Dis 2002;185:1709-1716.
39. Wills MR, Carmichael AJ, Mynard K, et al.: The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: Frequency, specificity, and T-cell receptor usage of pp65-specific CTL. J Virol 1996;70:7569-7579.
40. Beninga J, Kropff B, and Mach M: Comparative analysis of fourteen individual human cytomegalovirus proteins for helper T cell response. J Gen Virol 1995;76(Pt 1):153-160.
41. Trzonkowski P, Mysliwska J, Szmit E, et al.: Association between cytomegalovirus infection, enhanced proinflammatory response and low level of anti-hemagglutinins during the anti-influenza vaccination-an impact of immunosenescence. Vaccine 2003;21:3826-3836.
42. Bartlett DB, Firth CM, Phillips AC, et al.: The age-related increase in low-grade systemic inflammation (Inflammaging) is not driven by cytomegalovirus infection. Aging Cell 2012;11:912-915.
43. Bennett JM, Glaser R, Malarkey WB, et al.: Inflammation and reactivation of latent herpesviruses in older adults. Brain Behav Immun 2012;26:739-746.
44. Lichtner M, Cicconi P, Vita S, et al.: Cytomegalovirus coinfection is associated with an increased risk of severe non-AIDS-defining events in a large cohort of HIV-infected patients. J Infect Dis 2015;211:178.